ABSTRACT: A recombinant infectious hematopoietic necrosis vuus (IHNV) glycoprotein (G protein), produced in Spodoptera frugiperda (Sf9) cells following infechon with a baculowus vector containing the full-length (1.6 kb) glycoprotein gene, provided very limited protection in rainbow trout Oncorhynchus myluss challenged with IHNV. Fish were injected intrapentoneally (1.p.) with Sf9 cells grown at 20°C (RecGI,,") or 27°C (RecGhigh) expressing the glycoprotein gene. Various antigen (Ag) preparations were adrmnistered to adult rainbow trout or rainbow trout fry. Sera collected from adult fish were evaluated for IHNV neutralization activity by a complement-dependent neutralization assay. Anti-IHNV neutralizing activity was observed in sera, but the percent of fish responding was significantly lower (p < 0.05) in comparison to fish immunized with a low virulence strain of IHNV (LV-IHNV). A small number of fish immunized with RecG,,,, or R e~G~, ,~p o s s e s s e d IHNV G protein specific antibodies (Abs) in their serum. Cumulative mortality (CM) of rainbow trout fry (mean weight, 1 g) vaccinated by i.p. injection of freezekhawed Sf9 cells producing RecGI,,, was 18 % in initial trials following IHNV challenge. This level of protection was sign~ficant (p < 0.05) but was not long lasting, and neutraking Abs were not detected in pooled serum samples. When trout fry (mean weight, 0.6 g) were vacc~nated with supernatant collected from sonicated Sf9 cells, Sf9 cells producing RecG,,,, or Sf9 cells producing RecG,,,,,, CM averaged 46%. Protection was enhanced over negative controls, but not the positive controls (2 % CM), suggesting that in the first trial soluble cellular proteins may have provided some level of non-specific protection, regardless of recombinant protein expression. Although some immunity was elicited in fish, and RecG,,, provided shortterm protection from IHNV, Ab-mediated protection could not be demonstrated. The results suggest that recombinant G proteins produced in insect cells lack the immunogenicity associated with vaccination of fish with an attenuated strain of IHNV.
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This study evaluates the potential of a baculovirus derived recombinant IHNV vaccine to elicit humoral immune responses in rainbow trout and provide protection against IHNV challenge. The expression of genes in insect cells using baculovirus vectors has been extensively utilized as a means of producing fulllength functionally active proteins. Unlike bacterial cells, insect cells have the ability to glycosylate proteins in a eukaryotic manner (Luckow & Summers 1988 , Luckow 1991 , King & Possee 1992 . The glycoprotein (G protein) of IHNV is important in eliciting a protective immune response in fish (Engelking & Leong 1989) , and it is thought that a glycosylated G protein may enhance immunity over non-glycosylated products. Expression of the glycoprotein gene of IHNV in insect cells was first achieved by Koener & Leong (1990) , but the ability of that antigen (Ag) to elicit immunity to IHNV was not reported. Lecocq-Xhonneux et al. (1994) found that rainbow trout injected with insect cell lysates producing a baculovirus derived recombinant viral hemorrhagic septicaemia virus (VHSV) glycoprotein developed neutralizing Abs and were protected from lethal challenge.
Initial characterization of the baculovirus product developed for this study has revealed interesting temperature-dependent properties (Cain et al. 1998) . The recombinant glycoprotein, produced in insect cells Spodoptera frugiperda (Sf9) at 20°C (RecG,,,) , was shown to be transported and localized to the cell surface. In contrast, production at 27°C ( R~c G~, ,~) resulted in a protein which remained internalized within the cells. The results suggest that low temperature production may produce a more native product and agree with similar findings associated with the glycoprotein of VHSV (Lorenzen 1997) . The objective of this study was to evaluate the ability of fish to elicit neutraliz~ng antibodies and/or protective immunity following immunization with a baculovirus derived IHNV G protein produced in insect cells at 20 or 27'C.
Materials and methods. Fish stocks were obtained from Clear Springs Foods Inc., Buhl, Idaho, USA, and all immunizations and challenges were conducted at their research facility. Adult rainbow trout with no history of an IHNV infection were obtained from research lots of fish, which had been maintained in outside raceways prior to being moved into the research laboratory. Juvenile rainbow trout were hatched and reared in ultra-violet (UV) light treated specific pathogen free (SPF) spring water prior to vaccination trials. All experiments were conducted in tanks supplied with UVtreated SPF spring water with an ambient temperature of 15°C. (Fijan et al. 1983 ) were grown in minimal essential media (MEM, Gibco) supplemented with 10% fetal calf serum (FCS). An isolate of IHNV (220-90; LaPatra et al. 1991 ) and a low virulence IHNV strain (039-82; LaPatra et al. 1991) were propagated and assayed in EPC cells. Stocks of vlrus were obtained by harvest of cell culture lysate 6 to 8 d post-infection. A plaque assay (Burke & Mulcahy 1980) was performed on a sub-sample of the lysate and aliquots were stored at -75°C. Low virulence IHNV (LV-IHNV) was used for immunizations of fish while isolate 220-90 was utilized for virus challenges and complement dependent neutralization assays . Purified IHNV (Round Butte I isolate; previously described in Hsu et al. 1986, Ristow & Arnzen d e Avila 1991) was used for imrnunoblotting analysis, while recombinant baculovirus stocks and Sf9 cells were maintained as previously described (see 'Materials and methods ', Cain et al. 1998) .
IHNV and assays: Monolayers of Epithelioma papuiosum cyprini (EPC) cells
Immunization: Adult fish were tagged for individual identification prior to immunization. Simultaneously, serum was obtained from individual fish with no history of IHN and confirmed negative (titer ~2 0 ) for IHNV neutralization titers by the complement-dependent neutralization assay . In Trials 1-1 and 1-2, 8 treatment groups were established, and 60 adult rainbow trout were immunized in each trial (Table 1 ). In Trial 1-1 , fish (mean weight, 1400 g) were anesthetized with MS-222 (Argent chemical) and immunized by i.p. injection with 2 m1 of Ag. For those treatment groups receiving Freund's complete adjuvant (FCA), a 1:l mixture consisting of 1 m1 of each preparation and 1 m1 of FCA was emulsified just prior to injection. Immunization Trial 1-2 was designed similar to the first trial but fish were smaller (mean weight, 400 g) and only 1 m1 of each preparation with or without FCA was injected. In both trials, fish were maintained in 1140 1 circular tanks. Serum was collected from individual fish in each trial at 3 wk intervals and analyzed for IHNV neutralization titers. Fish were fasted 48 h prior to immunization or sera collection.
Vaccination and challenge: Vaccination trials (V-l and V-2) were set up to evaluate protective immunity to IHNV conferred to rainbow trout fry following injection of preparations of Sf9, RecG,,,, and RecG,,, cells. Treatments were identical in the 2 trials; however, Ag Table 1 . Oncorhynchus mykiss. Experimental design for adult rainbow trout immunized in trials (1-1 and 1-2). Treatment groups received either freeze/thawed cells or supernatant from an equal concentration of cells subjected to sonication followed by removal of cellular debris by centrifugation 
dDuplicate IHNV challenges were performed. Fish size at the second challenge given in parentheses b~r e a t m e n t s (Ags) administered in each trial included: Sf9 cells; RecG,,,,; R~c G~, ,~; rabbit sera containing anti-IHNV Ab titers (fish were passively immunized 24 h prior to challenge), and tissue culture media (injected 24 h prior to challenge as a negative control). Antigen preparation in Trial V-l included freezekhawed cells for the initial immunization followed by a booster immunization 4 wk later with supernatant from sonicated cells (shown in parentheses). Fish in Trial V-2 received only supernatant from sonicated cells both initially and as a booster immunization CLength of the study is given as weeks following initial immunization to time of first challenge. Number in parentheses indicates time repeat challenge performed on identically treated fish 5 wk post-booster of the fish, serum samples were not collected in Trial V-2. Virus isolation from dead fish in each trial was performed with kidney-liver-spleen homogenates collected from a minimum of 20% of the daily mortalities using a standard plaque assay (LaPatra et al. 1989 ).
Statistical analysis: The percentage of fish in Trials 1-1 and 1-2 which had positive IHNV neutralization titers was analysed by a 2-way analysis of variance (ANOVA). Treatment groups exhibiting statistical significance were isolated by a multiple comparison procedure. Cumulative percent mortality resulting from rainbow trout fry vaccinations followed by IHNV challenge was analysed using chisquare analysis. Values in all cases were considered significantly different at p values 50.05.
Results and discussion. In initial experimental trials, adult rainbow trout exhibpreparation differed (Table 2) . Fish were anaesthetised ited IHNV neutralizing Abs in sera from a low number with MS-222 and injected with 50 p1 of Ag for primary of fish immunized with preparations of either RecG,,,. and booster immunizations. Treatment groups (200 fish or RecGhigh (Table 3) , but the frequency of positives tank-') were maintained in 116 l tanks. Fish were held were not significantly different from control fish in the system for 6 wk following initial vaccinations injected with PBS or Sf9 cells emulsified in FCA. Neg-(2 wk post-booster), at which time a portion of the fish were removed and with IHNV' Remaining Freezekhawed cells 0 % (9) 0% (9) 22 Oh (9) Freeze/thawedcells/FCA 10%(10) 10%(10) 10%(10) Supernatant 10% (10) 0% (9) 0% (9) SupernatanWFCA 22% (9) 11% (9) Treatment group (1-2) 3 wk 6 wk 9 wk FreezeAhawed cells 0% (10) 20% (10) 10% (10) Freezehhawed ceUs/FCA 13 % (8) 38 % (8) 25 % (8) Supernatant 0% (9) 11 % (9) 22% (9) Supernatant/FCA 0% (7) 0% (7) 14.3% (7)
ative controls immunized with PBS alone (Trial 1-1) showed no serum neutralization activity in sera throughout the study, whereas fish injected with a low virulence strain of IHNV (LV-IHNV) seroconverted at a significant level. The ability of serum Abs to bind to the viral or recombinant G protein was evaluated by Western blot. Serum from a single fish immunized with RecGhigh emulsified in FCA that exhibited a neutralization titer of 2160 showed that G specific Abs were elicited and capable of recognizing reduced and non-reduced viral G protein (Fig. 1) . The lower band identified in the blot of the reduced virus is likely an unglycosylated G protein as it migrates at a similar molecular weight (MW). Serum tested by Western blot from fish immunized with preparations of RecG,,, also possessed Abs with the ability to recognize the IHNV G protein (data not shown). Lorenzen et al. (1993) Abs that only weakly recognized the recombinant G proteins, RecG,,, and RecGh,,,, (data not shown). Although Western blot results indicated that fish developed Abs to the G protein, the low percentage of fish seroconverting suggested that the antigenicity of recombinant preparations was low. It should be recognized that the use of a low virulence strain of virus would have established a subclinical infection in these fish resulting in continued stimulation of the immune system. Alternative positive controls for this expenment may have been a killed whole virus or purified viral G protein. An IHNV virus with low viruluence was chosen as a control in this study principally because it readily elicits a humoral response measured by neutralizing Abs to IHNV and it is capable of producing protection upon challenge. It was demonstrated that immunization by i.p. injection with freezehhawed Sf9 cells producing RecG,,, provided significant (p < 0.05) but short-term protection from IHNV challenge. Cumulative mortality in this treatment group was 18%, and the degree of protection observed compares with similar studies of rainbow trout immunized by i.p. injection of Sf9 cells producing a recombinant VHSV G protein emulsified in adjuvant and challenged by waterborne exposure to VHSV (Lecocq-Xhonneux et al. 1994) . Although results from this initial trial appeared promising, identically treated fish challenged 5 wk post-booster (V-lb) were susceptible to IHNV (Table 4) . Additionally, neutralizing Abs were not detected in pooled serum samples collected from vaccinated stocks. The protection observed suggested that low temperature expression of the G protein was responsible for specific protection. Since a control consisting of Sf9 cells grown at 20°C was not included in this first vaccination trial (V-la and V-lb), it cannot be ruled out that some property induced by the low temperature cultivation of cells (without baculovirus infection) may have been responsible for enhanced protection. Virus was re-isolated from 93 and 90% of mortalities sampled in the first trial and mean virus titers were 4 . 8 X 106 pfu ml-' and 2.6 X 106 pfu ml-l, respectively. Since long-term immunity is a critical requirement in the development of an efficacious vaccine (Leong & Fryer 1993) , our initial results raised concern.
Additional trials (V-2a and V-2b) to evaluate the ability of the 'sonicated' Ag to provide protection from virus challenge were conducted. Sonication of cells was considered important since the development of an irnmers~on-based vaccine would likely require the cellular dissociation and solublization of the G protein.
It is known that when the G protein of IHNV is stripped from the surface of the virus by treatment with Tr-ton X-100 ~t remains immunogenic to fish (Engelking & Leong 1989) . Sonication allowed the dissociation of Ag Table 4 Oncorhynchus m y k~s s Protection of rainbow trout fry follow~ng IHNV challenge Trials designated as V-la and V-2a ~n d~c a t e data were collected from IHNV challenge 2 wk post-booster, w h~l e V-lb a n d V-2b ~n d~c a t e data were collected following IHNV challenge of ~d e n t~c a l l y treated f~s h 5 wk post-booster N Replicate groups S i g n~f~c a n t differences ( p < 0 05) In cumulative percent mortality are indicated by different letters in subscript Relat~ve percent suivlval (RPS, Johnson et a1 1982) of vacc~nated over control fish was determined by the formula RPS = [ l -('%I loss of vaccindted fish/% loss of controls)] X 100 Note Positive control fish were pass~vely immun~zed with 50 p1 of a 1 25 dilution of rabbit anti-IHNV a n t~s e r u m 24 h pnor to challenge while negative control fish r e c e~v e d only t~s s u e culture media (Table 4) . Since protection in this trial was associated with all groups immunized with insect cells, regardless of recombinant protein expression, it is possible that non-specific components of the immune system were stimulated which enhanced cell-mediated immunity over negative control fish. When the challenge was repeated at 5 wk (V-2b), no protection was observed in fish from any of the vaccinated groups, but positive control groups again exhibited significantly lower (p i 0.05) mortality than negative controls. In Trials V-2a and V-2b, virus was re-isolated from 95 to 96% of mortalities sampled, and ranged in mean titer from 3.7 X 106 pfu ml-' to 5.1 X 10' pfu ml-l, respectively.
The results of this study provide evidence that a recombinant IHNV G protein produced in insect cells may elicit limited virus neutralizing Abs and may provide short duration protection in rainbow trout; however, these responses appear limited, and further analysis and purification of these recombinant products is needed. The short-term protection conferred by immunization in the first trial with RecGlo, appeared interesting, but in retrospect, irnrnunogenicity of R~c G~, ,~ and RecGlo, appears minimal. The properties of both G proteins tested here differ from the native IHNV glycoprotein (Cain et al. 1998) , which may explain the lack of immunostimulatory properties observed. Temperature manipulations during expression of recombinant proteins could prove crucial in future vaccine development, and as more information is obtained about the G protein of IHNV, a better immunogen may be developed. Results presented in this study emphasise the need for a greater understanding of the complex interactions of the fish immune system with the glycoprotein of IHNV.
